title: [Liver transplantation for advanced primary hepatocellular carcinoma].
abstract: OBJECTIVE
  To investigate the value of liver transplantation for late hepatocellular carcinoma.
  
  
  METHODS
  Thirty-six patients were treated by liver transplantation from August 2000 to February 2002, of which 15 patients had had advanced hepatocellular carcinoma and thirteen of these 15 patients were evaluated for results.
  
  
  RESULTS
  The 1-year survival rate was 86% (6/7). Only one patient died of recurrence within 6 months. The tumor-free survival was 5 to 19 months. Till February 2002, two patients have survived for 10 months and 19 months with recurrence.
  
  
  CONCLUSIONS
  In our country, if the patients can afford liver transplantation, advanced hepatocellular carcinoma without extrahepatic metastasis is still indicated for liver transplantation, since some patients may survive relatively long.
authors.affiliation: Department of General Surgery, Third Hospital of Peking University, Beijing 100083, China.
authors.forename: De-chen
authors.initials: DC
authors.lastname: Wang
authors.forename: Shi-bing
authors.initials: SB
authors.lastname: Song
authors.forename: Jiong
authors.initials: J
authors.lastname: Yuan
authors.forename: Dian-rong
authors.initials: DR
authors.lastname: Xiu
authors.forename: Jian-ping
authors.initials: JP
authors.lastname: Zhu
authors.forename: Bin
authors.initials: B
authors.lastname: Jiang
authors.forename: Tong-lin
authors.initials: TL
authors.lastname: Zhang
mesh_terms: D000328:Adult; D006528:Carcinoma, Hepatocellular / Q000401:mortality / Q000601:surgery*; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000401:mortality / Q000601:surgery*; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local